Literature DB >> 1295028

Infratentorial stereotactic biopsy. A review of 11 cases.

T C Ryken1, P W Hitchon, R M Roach, V C Traynelis.   

Abstract

A review of the stereotactic cases performed at the University of Iowa between February, 1985, and December, 1990, yielded 12 infratentorial stereotactic biopsies in 11 patients. A definitive diagnosis was obtained in 9 of 11 patients. One patient required a second biopsy to obtain a diagnosis and 1 yielded cystic fluid only. The pathological diagnosis obtained included 4 high-grade gliomas, 2 undifferentiated adenocarcinomas, 2 low-grade astrocytomas, 1 malignant ependymoma, 1 pontine hematoma and 1 cyst. None of the patients experienced increased neurological deficit following biopsy and there was no mortality. One patient developed postoperative meningitis. We conclude that stereotactic biopsy of infratentorial lesions can be performed safely with a high probability of obtaining a diagnosis. Adequate tissue diagnosis is necessary to direct further therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1295028     DOI: 10.1159/000098926

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  3 in total

1.  Stereotactic Transcerebellar Approach to Pontine Lesions through the Middle Cerebellar Peduncle.

Authors:  P Parker; M F Levesque; J Bittoun; D Doyon; M Tadie
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

2.  Stereotactic biopsy for intrinsic lesions of the medulla through the long-axis of the brainstem: technical considerations.

Authors:  D Kondziolka; L D Lunsford
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Stereotactic Biopsy for Brainstem Lesions: A Meta-analysis with Noncomparative Binary Data.

Authors:  Lin He; Dongjie He; Yuhong Qi; Jiejing Zhou; Canliang Yuan; Hao Chang; Qiming Wang; Gaiyan Li; Qiuju Shao
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.